Bendamustine, Pomalidomide, and Dexamethasone for Relapsed and/or Refractory Multiple Myeloma
Blood Cancer Journal - United States
doi 10.1038/s41408-018-0104-5
Full Text
Open PDFAbstract
Available in full text
Date
July 31, 2018
Authors
Publisher
Springer Science and Business Media LLC